{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:46:36Z","timestamp":1782927996530,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijcard.2026.134631","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:08:06Z","timestamp":1781737686000},"page":"134631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rate of incident polyneuropathy in patients with transthyretin amyloid cardiomyopathy"],"prefix":"10.1016","volume":"460","author":[{"given":"Laura M.G.","family":"Meems","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Ohlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ciaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"H\u00e4ckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Oberm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Vivirito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig I.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Fernandez","family":"de Sanmamed Gir\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2026.134631_bb0005","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2026.134631_bb0010","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology solution set oversight committee","volume":"81","author":"Writing Committee","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134631_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134631_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134631_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.puhe.2022.02.013","article-title":"Sampling strategy, characteristics and representativeness of the InGef research database","volume":"206","author":"Ludwig","year":"2022","journal-title":"Public Health"},{"key":"10.1016\/j.ijcard.2026.134631_bb0030","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1080\/03007995.2025.2596820","article-title":"Methods of identifying transthyretin amyloid cardiomyopathy in secondary data sources: a systematic review","volume":"41","author":"Coleman","year":"2025","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ijcard.2026.134631_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13023-023-02933-w","article-title":"Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases","volume":"18","author":"Damy","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ijcard.2026.134631_bb0040","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/ehf2.14736","article-title":"Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan","volume":"11","author":"Kato","year":"2024","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134631_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ahj.2023.06.013","article-title":"Transthyretin amyloid cardiomyopathy among patients hospitalized for heart failure and performance of an adapted wild-type ATTR-CM machine learning model: findings from GWTG-HF","volume":"265","author":"Peters","year":"2023","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2026.134631_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10654-019-00500-x","article-title":"Guidelines and recommendations for ensuring good epidemiological practice (GEP): a guideline developed by the German Society for Epidemiology","volume":"34","author":"Hoffmann","year":"2019","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.ijcard.2026.134631_bb0055","article-title":"AmyKoS\u2014a German real-world prospective cohort study of patients with suspected and proven amyloidosis","volume":"3","author":"Ihne-Schubert","year":"2024","journal-title":"J. Rare Dis."},{"key":"10.1016\/j.ijcard.2026.134631_bb0060","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1212\/WNL.0000000000003293","article-title":"Prevalence of polyneuropathy in the general middle-aged and elderly population","volume":"87","author":"Hanewinckel","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ijcard.2026.134631_bb0065","doi-asserted-by":"crossref","first-page":"1345608","DOI":"10.3389\/fcvm.2024.1345608","article-title":"Neuromuscular manifestations of wild type transthyretin amyloidosis: a review and single center\u2019s experience","volume":"11","author":"\u017divkovi\u0107","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2026.134631_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40119-023-00344-3","article-title":"Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the Transthyretin Amyloidosis Outcomes Survey","volume":"13","author":"Gonz\u00e1lez-Moreno","year":"2024","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.ijcard.2026.134631_bb0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/13506129.2021.2014448","article-title":"Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis","volume":"29","author":"Kleefeld","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.ijcard.2026.134631_bb0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/13506129.2019.1697224","article-title":"Late-onset peripheral neuropathy in patients with wild type transthyretin amyloidosis (wtATTR)","volume":"27","author":"\u017divkovi\u0107","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.ijcard.2026.134631_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011796","article-title":"Guideline-directed medical therapy for heart failure in transthyretin amyloid cardiomyopathy","volume":"18","author":"Schwarting","year":"2025","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134631_bb0090","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehad347","article-title":"Conventional heart failure therapy in cardiac ATTR amyloidosis","volume":"44","author":"Ioannou","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134631_bb0095","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2024.03.429","article-title":"SGLT2 inhibitor therapy in patients with transthyretin amyloid cardiomyopathy","volume":"83","author":"Porcari","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134631_bb0100","first-page":"215","article-title":"Administrative databases and outcomes assessment: an overview of issues and potential utility","volume":"5","author":"Gandhi","year":"1999","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.ijcard.2026.134631_bb0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacc.2025.09.004","article-title":"Transthyretin cardiac amyloidosis evaluation and management: 2025 ACC concise clinical guidance","volume":"87","author":"Writing Committee","year":"2026","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732600481X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732600481X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:01:01Z","timestamp":1782925261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732600481X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"alternative-id":["S016752732600481X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134631","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate of incident polyneuropathy in patients with transthyretin amyloid cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134631"}}